Augmenix

Dear ESTRO Attendees, We are delighted to sponsor a satellite symposium to share the latest clinical updates on SpaceOAR® Hydrogel. Used in prostate cancer radiotherapy at many leading cancer centers, SpaceOAR is an absorbable hydrogel that temporarily moves the rectum away from the prostate and the high radiation zone. The space created significantly reduces the radiation delivered to the rectum while allowing increased dosage to the prostate and has demonstrated favorable bowel, urinary and sexual patient reported QOL outcomes. Dr. Michael Zelefsky from Memorial Sloane Kettering Cancer Center will present his experience using SpaceOAR hydrogel for high-dose prostate cancer radiotherapy, and Dr. Jeff Michalski from Washington University School of Medicine will discuss how rectal spacing improves prostate cancer radiation therapy. The session will be moderated by Dr. Ben Vanneste from the MAASTRO Clinic. To learn more please visit the Augmenix booth #2950 or spaceoar.com